Thyroid

Papers
(The H4-Index of Thyroid is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
Role of Thyrotropin-Releasing Hormone in Regulating Fibroblast Growth Factor 21 in Mouse Pancreatic β Cells472
Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations259
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease197
Future Meetings137
35th Anniversary of Thyroid—Journal of the American Thyroid Association105
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Thyroid103
Regular Call Oral Abstracts91
International Women’s Day: An Occasion for a Tribute to Women Leaders in the American Thyroid Association84
Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al.81
Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions81
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction77
Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer74
A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal69
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)68
Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy63
Discoveries Around the Hypothalamic–Pituitary–Thyroid Axis59
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study54
Letter to the Editor: ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma52
Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants51
A Conversation with Samuel Refetoff, MD: How Treating One Family Stimulated a Lifelong Series of Major Discoveries in Thyroid Physiology and Disease46
The Scientific Contributions of Martin Surks, MD, MACP: A Pioneer in Thyroid Hormone Physiology, Subclinical Hypothyroidism, and Endocrine Education43
Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up42
A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications41
The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005–202041
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion40
Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature40
Correction to: The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differe39
Preliminary Evidence of Potential Association Between Exposure to Estriol-Containing Skincare Cosmetics Sold in China and Autoimmune Thyroid Disease39
Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma37
The American Thyroid Association 1923–2023: Honoring Our Past, Embracing Our Future36
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Rece35
The Year in Thyroidology: Surgical Science34
Abstract Author Index34
0.17260193824768